Carlo M Croce MD


Carlo M Croce MD
ChairCollege of Medicinecroce.5@osu.edu
1082 Biomedical Research Tower 460 W 12th Avenue Columbus Ohio 43210
Phone:614-292-3063Fax: 614-292-4080
  • Molecular Biology and Cancer Genetics
  • Administrative

Current Publications

  • Baldassarre GContact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.Oncotarget 5 1185-97 5/1/2014
  • Visone RAllele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.Leukemia 4/15/2014
  • Croce CMMicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer.Cancer Cell 25 469-83 4/14/2014
  • Garzon RImplications of the miR-10 family in chemotherapy response of NPM1-mutated AML.Blood 123 2412-5 4/10/2014
  • Zhang M, Luo Z, Liu H, Croce CM, Burke TR Jr, Bottaro DPSynergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist.Leukemia 28 948-51 4/1/2014
  • Vecchione ALZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.Oncotarget 5 970-7 4/1/2014
  • Croce CMProtective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.Proc Natl Acad Sci U S A 111 4536-41 3/25/2014
  • Croce CMMicrovesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.Proc Natl Acad Sci U S A 111 4525-9 3/25/2014
  • Di Nicola MPleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.Int J Cancer 3/20/2014
  • Croce CMLong-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.Proc Natl Acad Sci U S A 111 4173-8 3/18/2014
  • Mackay FCytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia.Leukemia 3/18/2014
  • Cavenee WKSuppression of MicroRNA-9 by Mutant EGFR Signaling Upregulates FOXP1 to Enhance Glioblastoma Tumorigenicity.Cancer Res 74 1429-39 3/1/2014
  • Pileri SAMolecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.Leukemia 2/7/2014
  • Croce CMMicroRNAs as Anti-Cancer Therapy.Curr Pharm Des 1/28/2014
  • Croce CMWill detection of microRNA biomarkers in blood improve the diagnosis and survival of patients with pancreatic cancer?JAMA 311 363-5 1/22/2014
  • Muthusamy NThe CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model.Leukemia 1/21/2014
  • Huebner KmicroRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.Oncotarget 1/21/2014
  • Kipps TJROR1 can interact with TCL1 and enhance leukemogenesis in Eµ-TCL1 transgenic mice.Proc Natl Acad Sci U S A 111 793-8 1/14/2014
  • Huebner KAndrogen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.PLoS One 9 e88525 1/1/2014
  • Lavigne JEffects of Calorie Restriction and Diet-Induced Obesity on Murine Colon Carcinogenesis, Growth and Inflammatory Factors, and MicroRNA Expression.PLoS One 9 e94765 1/1/2014
  • Calin GALong Noncoding RNA in Prostate, Bladder, and Kidney Cancer.Eur Urol 12/14/2013
  • Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino GProtumorigenic effects of mir-145 loss in malignant pleural mesothelioma.Oncogene 11/18/2013
  • Sandhu SK, Fassan M, Volinia S, Lovat F, Balatti V, Pekarsky Y, Croce CMB-cell malignancies in microRNA Eµ-miR-17~92 transgenic mice.Proc Natl Acad Sci U S A 110 18208-13 11/5/2013
  • Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, Lehman A, Ruppert AS, Bolon B, Andritsos L, Lozanski A, Rassenti L, Zhao W, Jarvinen TM, Senter L, Croce CM, Symer DE, de la Chapelle A, Heerema NA, Byrd JCCharacterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.PLoS One 8(10) e76607 10/9/2013
  • Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, Sun C, Saddoughi SA, Bielawski J, Blum W, Klisovic RB, Solt JA, Byrd JC, Volinia S, Cortes J, Huettner CS, Koschmieder S, Holyoake TL, Devine S, Caligiuri MA, Croce CM, Garzon R, Ogretmen B, Arlinghaus RB, Chen CS, Bittman R, Hokland P, Roy DC, Milojkovic D, Apperley J, Goldman JM, Reid A, Mulloy JC, Bhatia R, Marcucci G, Perrotti DPP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.J Clin Invest 123(10) 4144-57 10/1/2013
  • Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce C, Chakravarti A, Victor J, Lautenschlaeger TMicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.Clin Cancer Res 19(19) 5423-33 10/1/2013
  • Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB, Bloomston MHypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells.J Surg Res 184(2) 855-60 10/1/2013
  • Di Leva G, Garofalo M, Croce CMMicroRNAs in Cancer.Annu Rev Pathol in press 9/25/2013
  • Collins AL, Wojcik S, Liu J, Frankel WL, Alder H, Yu L, Schmittgen TD, Croce CM, Bloomston MA Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma.Ann Surg Oncol in press 9/18/2013
  • Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, Liu L, Luo Z, Sun HL, Cui R, Wei H, Kim T, Lee TJ, Jeon YJ, Nuovo GJ, Volinia S, He Q, Yu J, Nana-Sinkam P, Croce CMInsulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer.Proc Natl Acad Sci U S A 110(37) 15043-8 9/10/2013
  • Hudson RS, Yi M, Esposito D, Glynn SA, Starks AM, Yang Y, Schetter AJ, Watkins SK, Hurwitz AA, Dorsey TH, Stephens RM, Croce CM, Ambs SMicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.Oncogene 32(35) 4139-47 8/29/2013
  • Yaseen Balkhi M, Iwenofu OH, Bakkar N, Ladner KJ, Chandler DS, Houghton PJ, London CA, Kraybill W, Perrotti D, Croce CM, Keller C, Guttridge DCmiR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.Sci Signal 6(286) ra63 7/30/2013
  • Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CMA microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.Proc Natl Acad Sci U S A 110(24) 9845-50 6/11/2013
  • Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CMToll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.Proc Natl Acad Sci U S A 110(24) 9812-7 6/11/2013
  • Croce CMMicroRNA dysregulation in acute myeloid leukemia.J Clin Oncol 31(17) 2065-6 6/10/2013
  • Garofalo M, Croce CMMicroRNAs as therapeutic targets in chemoresistance.Drug Resist Updat in press 6/8/2013
  • Chen Y, Jacamo R, Konopleva M, Garzon R, Croce C, Andreeff MCXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.J Clin Invest 123(6) 2395-407 6/3/2013
  • Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco AThe High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.Mol Oncol 7(3) 531-42 6/1/2013
  • Zanesi N, Balatti V, Riordan J, Burch A, Rizzotto L, Palamarchuk A, Cascione L, Lagana A, Dupuy AJ, Croce CM, Pekarsky YA Sleeping Beauty screen reveals NF-kB activation in CLL mouse model.Blood 121(21) 4355-8 5/23/2013
  • Acunzo M, Romano G, Palmieri D, Laganá A, Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P, Croce CMCross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.Proc Natl Acad Sci U S A 110(21) 8573-8 5/21/2013
  • Fassan M, Volinia S, Palatini J, Pizzi M, Fernandez-Cymering C, Balistreri M, Realdon S, Battaglia G, Souza R, Odze RD, Zaninotto G, Croce CM, Rugge Md Facg MMicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia.Clin Transl Gastroenterol 4 e34 5/16/2013
  • Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso FDiscovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation.ACS Chem Biol in press 5/13/2013
  • Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CMIn vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.J Exp Med 210(5) 951-68 5/6/2013
  • Tili E, Michaille JJ, Croce CMMicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.Immunol Rev 253(1) 167-84 5/1/2013
  • Volinia S, Croce CMPrognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.Proc Natl Acad Sci U S A 110(18) 7413-7 4/30/2013
  • Trotta R, Chen L, Costinean S, Josyula S, Mundy-Bosse BL, Ciarlariello D, Mao C, Briercheck EL, McConnell KK, Mishra A, Yu L, Croce CM, Caligiuri MAOverexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.Blood 121(16) 3126-34 4/18/2013
  • Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CMCorrection: Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status.PLoS Genet 9(4) 4/1/2013
  • Balatti V, Lerner S, Rizzotto L, Rassenti LZ, Bottoni A, Palamarchuk A, Cascione L, Alder H, Keating MJ, Kipps TJ, Pekarsky Y, Croce CMTrisomy 12 CLLs progress through NOTCH1 mutations.Leukemia 27(3) 740-3 3/1/2013
  • Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CMLoss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.Oncogene in press 2/18/2013
  • Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs STranscription signatures encoded by ultraconserved genomic regions in human prostate cancer.Mol Cancer 12 13 2/14/2013
  • Di Leva G, Croce CMmiRNA profiling of cancer.Curr Opin Genet Dev 23(1) 3-11 2/1/2013
  • Fabbri M, Paone A, Calore F, Galli R, Croce CMA new role for microRNAs, as ligands of Toll-like receptors.RNA Biol 10(2) 169-74 2/1/2013
  • Gaudio E, Paduano F, Ngankeu A, Lovat F, Fabbri M, Sun HL, Gasparini P, Efanov A, Peng Y, Zanesi N, Shuaib MA, Rassenti LZ, Kipps TJ, Li C, Aqeilan RI, Lesinski GB, Trapasso F, Croce CMHeat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.Blood 121(2) 351-9 1/10/2013
  • Iorio MV, Croce CMMicroRNA profiling in ovarian cancer.Methods Mol Biol 1049 187-97 1/1/2013
  • Nana-Sinkam SP, Croce CMClinical applications for microRNAs in cancer.Clin Pharmacol Ther 93(1) 98-104 1/1/2013
  • Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Ramasamy S, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CMEstrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.PLoS Genet 9(3) e1003311 1/1/2013
  • Balatti V, Pekarky Y, Rizzotto L, Croce CMmiR Deregulation in CLL.Adv Exp Med Biol 792 309-25 1/1/2013
  • Laganà A, Russo F, Veneziano D, Bella SD, Giugno R, Pulvirenti A, Croce CM, Ferro AExtracellular circulating viral microRNAs: current knowledge and perspectives.Front Genet 4 120 1/1/2013
  • Di Leva G, Croce CMThe Role of microRNAs in the Tumorigenesis of Ovarian Cancer.Front Oncol 3 153 1/1/2013
  • Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner KIntegrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.PLoS One 8(2) e55910 1/1/2013
  • Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CMMiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.PLoS One 8(6) e67581 1/1/2013
  • Gaudio E, Paduano F, Spizzo R, Ngankeu A, Zanesi N, Gaspari M, Ortuso F, Lovat F, Rock J, Hill GA, Kaou M, Cuda G, Aqeilan RI, Alcaro S, Croce CM, Trapasso FFhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to Paclitaxel.PLoS One 8 e78610 1/1/2013
  • Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, Gordon JA, Li Z, Croce CM, Van Wijnen AJ, Stein JL, Stein GS, Lian JBmiR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells.J Biol Chem 287(50) 42084-92 12/7/2012
  • Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, Parthun MR, Perrotti D, Marcucci G, Garzon R, Croce CMmiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.Proc Natl Acad Sci U S A 109(49) 20047-52 12/4/2012
  • Laganà A, Paone A, Veneziano D, Cascione L, Gasparini P, Carasi S, Russo F, Nigita G, Macca V, Giugno R, Pulvirenti A, Shasha D, Ferro A, Croce CMmiR-EdiTar: a database of predicted A-to-I edited miRNA target sites.Bioinformatics 28(23) 3166-8 12/1/2012
  • Colamaio M, Calì G, Sarnataro D, Borbone E, Pallante P, Decaussin-Petrucci M, Nitsch L, Croce CM, Battista S, Fusco ALet-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.J Clin Endocrinol Metab 97(11) E2168-78 11/1/2012
  • Paduano F, Ortuso F, Campiglia P, Raso C, Iaccino E, Gaspari M, Gaudio E, Mangone G, Carotenuto A, Bilotta A, Narciso D, Palmieri C, Agosti V, Artese A, Gomez-Monterrey I, Sala M, Cuda G, Iuliano R, Perrotti N, Scala G, Viglietto G, Alcaro S, Croce CM, Novellino E, Fusco A, Trapasso FIsolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.ACS Chem Biol 7(10) 1666-76 10/19/2012
  • Taccioli C, Chen H, Jiang Y, Liu XP, Huang K, Smalley KJ, Farber JL, Croce CM, Fong LYDietary zinc deficiency fuels esophageal cancer development by inducing a distinct inflammatory signature.Oncogene 31(42) 4550-8 10/18/2012
  • Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C, Bolon B, Condorelli G, Croce CMMiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.Proc Natl Acad Sci U S A 109(41) 16570-5 10/9/2012
  • Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CMThe down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.Blood 120(13) 2631-8 9/27/2012
  • Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LYDysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.Carcinogenesis 33(9) 1736-44 9/1/2012
  • Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corrà F, Miotto E, Lupini L, Bolondi L, Gramantieri L, Croce CM, Sabbioni S, Negrini MLiver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.Hepatology 56(3) 1025-33 9/1/2012
  • Ranganathan P, Yu X, Na C, Santhanam R, Shacham S, Kauffman M, Walker A, Klisovic R, Blum W, Caligiuri M, Croce CM, Marcucci G, Garzon RPreclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.Blood 120(9) 1765-73 8/30/2012
  • Smith KM, Guerau-de-Arellano M, Costinean S, Williams JL, Bottoni A, Mavrikis Cox G, Satoskar AR, Croce CM, Racke MK, Lovett-Racke AE, Whitacre CCmiR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.J Immunol 189(4) 1567-76 8/15/2012
  • Kriss CL, Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu CCOverexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.Blood 120(5) 1027-38 8/2/2012
  • Mathé E, Nguyen GH, Funamizu N, He P, Moake M, Croce CM, Hussain SPInflammation regulates microRNA expression in cooperation with p53 and nitric oxide.Int J Cancer 131(3) 760-5 8/1/2012
  • Piovan C, Palmieri D, Di Leva G, Braccioli L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi T, Taccioli C, Tagliabue E, Iorio MV, Croce CMOncosuppressive role of p53-induced miR-205 in triple negative breast cancer.Mol Oncol 6(4) 458-72 8/1/2012
  • Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CMMicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.Proc Natl Acad Sci U S A 109(31) E2110-6 7/31/2012
  • Wang H, Chiu M, Xie Z, Chiu M, Liu Z, Chen P, Liu S, Byrd JC, Muthusamy N, Garzon R, Croce CM, Marcucci G, Chan KKSynthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity.Mol Pharm 9(6) 1638-44 6/4/2012
  • Iorio MV, Croce CMmicroRNA involvement in human cancer.Carcinogenesis 33(6) 1126-33 6/1/2012
  • Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele MPOZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.J Biol Chem 287(22) 18308-17 5/25/2012
  • Ranganathan P, Heaphy CE, Costinean S, Stauffer N, Na C, Hamadani M, Santhanam R, Mao C, Taylor PA, Sandhu S, He G, Shana'ah A, Nuovo GJ, Lagana A, Cascione L, Obad S, Broom O, Kauppinen S, Byrd JC, Caligiuri MA, Perrotti D, Hadley GA, Marcucci G, Devine SM, Blazar BR, Croce CM, Garzon RRegulation of acute graft-versus-host disease by microRNA-155.Blood 119(20) 4786-97 5/17/2012
  • Di Leva G, Briskin D, Croce CMMicroRNA in cancer: new hopes for antineoplastic chemotherapy.Ups J Med Sci 117(2) 202-16 5/1/2012
  • Iorio MV, Croce CMCauses and consequences of microRNA dysregulation.Cancer J 18(3) 215-22 5/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu